ACADIAN ASSET MANAGEMENT LLC

Position in PYXS — Pyxis Oncology, Inc.

CIK 916542 Boston, MA

Position in PYXS

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$210,613

+$114,971 QoQ

Shares Held

144,256

+234.8% QoQ

Ownership

0.228%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#21

of 78 holders

Holding Since

Jun 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ACADIAN ASSET MANAGEMENT LLC holds $659,552,548 across 178 Biotechnology names. PYXS ranks #112 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	1,900,824	$178,905,554
2	REGN	Regeneron Pharmaceuticals, Inc.	151,191	$116,816,214
3	LEGN	Legend Biotech Corp	1,527,336	$27,629,508
4	TBPH	Theravance Biopharma, Inc.	1,276,576	$20,718,828
5	RIGL	Rigel Pharmaceuticals Inc	666,426	$18,020,159
6	IMCR	Immunocore Holdings plc	501,091	$15,107,893
7	PRTA	Prothena Corp Public Ltd Co	1,547,593	$15,042,603
8	PBYI	Puma Biotechnology, Inc.	2,041,759	$13,046,840

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$210,613	144,256	+234.8%	Shares	Defined	2026-05-13
2025-09-30	$95,642	43,082	+127.4%	Shares	Defined	2025-11-13
2025-06-30	$20,836	18,942	-77.5%	Shares	Defined	2025-08-07
2025-03-31	$82,439	84,122	+645.9%	Shares	Defined	2025-05-21
2023-12-31	$20,300	11,278	-14.8%	Shares	Defined	2024-02-13
2023-09-30	$26,333	13,233	-59.3%	Shares	Defined	2023-11-13
2023-03-31	$130,349	32,506	-54.7%	Shares	Defined	2023-05-11
2022-12-31	$96,080	71,702	+200.7%	Shares	Defined	2023-02-14
2022-09-30	$46,970	23,843	0.0%	Shares	Defined	2022-11-14
2022-06-30	$56,746	23,843	—	Shares	Defined	2022-08-09
No filing history on record for this holder in this stock.